| Brand name | Nonproprietary Name | Authorization date | Marketing authorisation holder |
|---|---|---|---|
| GONAL-f | follitropin alfa | 1995-10-20 | Merck Europe B.V. |
| Taxotere | docetaxel | 1995-11-27 | Sanofi Mature IP |
| Betaferon | interferon beta-1b | 1995-11-30 | Bayer AG? |
| CellCept | mycophenolate mofetil | 1996-02-14 | Roche Registration GmbH |
| Fareston | toremifene | 1996-02-14 | Orion Corporation |
| NovoSeven | eptacog alfa (activated) | 1996-02-23 | Novo Nordisk A/S |
| Humalog | insulin lispro | 1996-04-30 | Eli Lilly Nederland B.V. |
| Puregon | follitropin beta | 1996-05-02 | N.V. Organon |
| Zerit | stavudine | 1996-05-08 | Bristol-Myers Squibb Pharma EEIG |
| Rilutek | riluzole | 1996-06-10 | Sanofi Mature IP |
| Caelyx pegylated liposomal | doxorubicin | 1996-06-20 | Baxter Holding B.V. |
| Bondronat | ibandronic acid | 1996-06-25 | Atnahs Pharma Netherlands B.V. |
| Destara | ibandronic acid | 1996-06-25 | Roche Registration Ltd. |
| Tritanrix HepB | diphtheria (D), tetanus (T), pertussis (whole cell) (Pw) and hepatitis B (rDNA) (HBV) vaccine (adsorbed) | 1996-07-19 | GlaxoSmithKline Biologicals S.A. |
| Epivir | lamivudine | 1996-08-08 | ViiV Healthcare BV |
| Norvir | ritonavir | 1996-08-25 | AbbVie Deutschland GmbH Co. KG |
| Rapilysin | reteplase | 1996-08-29 | Actavis Group PTC ehf |
| Ecokinase | reteplase | 1996-08-29 | Roche Registration Ltd. |
| Tecnemab K1 | anti-melanoma mab fragments | 1996-09-05 | Amersham Sorin.S.r.l. |
| Twinrix Adult | hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) | 1996-09-19 | GlaxoSmithKline Biologicals S.A. |